summary
Introduced
09/12/2024
09/12/2024
In Committee
09/12/2024
09/12/2024
Crossed Over
12/16/2024
12/16/2024
Passed
Dead
01/03/2025
01/03/2025
Introduced Session
118th Congress
Bill Summary
AN ACT To require the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to publish a final rule relating to nonclinical testing methods.
AI Summary
This bill, the FDA Modernization Act 3.0, requires the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to publish an interim final rule within one year of the bill's enactment. The rule will replace references to "animal" tests, data, studies, models, and research with "nonclinical" tests, data, studies, models, and research in various sections of the Code of Federal Regulations related to new drug applications and other FDA regulations. The bill also defines the term "nonclinical test" in the relevant sections of the regulations. Additionally, the bill makes a technical amendment to the Federal Food, Drug, and Cosmetic Act to designate a new subsection.
Committee Categories
Health and Social Services
Sponsors (10)
Cory Booker (D)*,
Richard Blumenthal (D),
Mike Braun (R),
John Neely Kennedy (R),
Angus King (I),
Ben Ray Luján (D),
Roger Marshall (R),
Rand Paul (R),
Eric Schmitt (R),
Sheldon Whitehouse (D),
Last Action
Held at the desk. (on 12/16/2024)
Bill Topics
Health
- ‐ Regulation of Drug Industry and Pharmacies
- ‐ Research and Development
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location | Created |
|---|---|---|
| State Bill Page | https://www.congress.gov/bill/118th-congress/senate-bill/5046/all-info | 09/13/2024 |
| BillText | https://www.congress.gov/118/bills/s5046/BILLS-118s5046es.pdf | 12/13/2024 |
| BillText | https://www.congress.gov/118/bills/s5046/BILLS-118s5046is.pdf | 09/24/2024 |
Loading...